MORISHITA Ryuichi | Department of Clinical Gene Therapy, Osaka University

スポンサーリンク

概要

関連著者

もっと見る

著作論文

Characteristics of Chronic Rejection in Heart Transplantation : Important Elements of Pathogenesis and Future Treatments
Does therapeutic angiogenesis overcome CKD?
Prevention of osteoporosis by angiotensin-converting enzyme inhibitor in spontaneous hypertensive rats
Genetic basis of hypertension for the development of tailored medicine
DPJ-013 Hepatocyte Growth Factor Attenuates TGF-β1 Angiotensin II Crosstalk by Down Regulation of Angiotensin II Type 1 Receptor through PTEN/Akt Pathway(DPJ03,Kidney/Renal Circulation/CKD (H),Digital Poster Session (Japanese),The 73rd Annual Scientific M
Serum hepatocyte growth factor concentration is a specific marker of endothelial dysfunction in humans
Anti-Aging Medicine in Cardiovascular Disease
FRS-003 Docking Protein Gab1 is Essential for HGF-dependent Endothelial Signaling and Angiogenesis after Hindlimb Ischemia(FRS1,New Molecules for Cardiovascular Regulation (M),Featured Research Session (English),The 73rd Annual Scientific Meeting of The J
PE-062 Zyxin Progresses Epithelial-Mesenchymal Transition under the Control of Twist1 and Contributes to Endocardial Morphogenesis(PE011,Congenital Heart Disease (M),Poster Session (English),The 73rd Annual Scientific Meeting of The Japanese Circulation S
The challenge of stopping the knocking down of metabolic dominos upstream
OE-137 Pivotal Roles of Inflammatory Factors in Arteriosclerosis and its Specific Regulation(Infection/Inflammation/Immunity-1, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
FRS-117 An Initial Result of 2-Year Follow Up of 17 Clinical Cases With an NF-κ B Decoy Transfection at the Coronary Stenting(Coronary Revascularization (clinical) 2, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
Initial Clinical Cases of the Use of a NF-κB Decoy at the Site of Coronary Stenting for the Prevention of Restenosis
OJ-094 Delayed Post-ischemic Treatment with Fluvastatin Improved Learning and Memory Deficit After Stroke in Rats without affecting Infarction Volume(Cerebrovascular circulation / Stroke-1, The 71st Annual Scientific Meeting of the Japanese Circulation So
PJ-740 Hepatocyte Growth Factor (HGF), but not Vascular Endothelial Growth Factor (VEGF), Attenuated Ang II-induced EC Senescence by Inhibiting PIP3/rac1 Activity(PJ124,Peripheral Cirulation/Vascular Disease (Therapy) 4 (H),Poster Session (Japanese),The 7
OJ-060 Hepatocyte Growth Factor Attenuate Ang II-induced Inflammation and Proliferation of Smooth Muscle Cell through EGF Receptor Degradation(OJ10,Atherosclerosis, Basic (IHD),Oral Presentation (Japanese),The 73rd Annual Scientific Meeting of The Japanes
Hepatocyte Growth Factor(HGF) as a Potential Index of Severity of Hypertension
IS033 UP-REGULATION OF KEY TRANSCRIPTIONAL FACTOR FOR ANGIOGENESIS, ETS, AND INDUCTION OF ANGIOGENESIS BY IN VIVO GENE TRANSFER OF HUMAN HEPATOCYTE GROWTH FACTOR (HGF) INTO MYOCARDIUM
IS028 GENE THERAPY OF RESTENOSIS BY IN VIVO GENE TRANSFER OF HUMAN HEPATOCYTE GROWTH FACTOR (HGF) THROUGH THE ACCELATION OF RE-ENDOTHELIALIZATION
Contribution of a Vascular Modulator, Hepatocyte Growth factor (HGF), to the Pathogenesis of Cardiovascular Disease
Potential Role of a Novel Vascular Modulator, Hepatocyte Growth Factor (HGF), in Cardiovascular Disease: Characterization and Regulation of Local HGF System
2 Estrogen Decreases the Activation of RANK-RANKL System in Vascular Calcification(Young Investigator's Award for International Students Finalists Lecture (YIA International),The 73rd Annual Scientific Meeting of The Japanese Circulation Society)
PJ-345 Hepatocyte Growth Factor Attenuates Angiotensin II Induced Renal Fibrosis through TGF-B Suppression by Anoikis of Myofibroblasts(Kidney/Renal circulation(06)(H),Poster Session(Japanese),The 72nd Annual Scientific Meeting of the Japanese Circulation
PJ-762 Requirement of HIF-1a Signaling on the Expression of Nkx2.5 for Normal Heart Developement in Xenopus(Development and differentiation-2, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
PE-114 Angiotensin II Blocker, Valsartan, Supresses the Development of Experimental Abdominal Aortic Aneurysm in Rats(Peripheral circulation/Vascular disease(03)(H),Poster Session(English),The 72nd Annual Scientific Meeting of the Japanese Circulation Soc
Inhibition of Restenosis by Beraprost Sodium (a Prostaglandin 12 Analogue) in the Porcine Coronary Artery after Angioplasty
OJ-213 Prevention of Abdominal Aortic Aneurysm using Ribbon-type Chimeric Decoy Oligodeoxynucleotides against NF κ B and Ets in a Rat Model(Genetics/Genetically engineered models/Gene therapy-2(H/M), The 71st Annual Scientific Meeting of the Japanese Circ
OJ-028 Role of NF κ B and Ets in Development of Abdominal Aortic Aneurysm in Human(Peripheral circulation/Vascular disease-2, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
Overexpression of HGF (Hepatocyte Growth Factor) Reduced Ischemic Injury in Rat Permanent Middle Cerebral Artery Occlusion (MCAO) Model
Therapeutic Angiogenesis Induced by Transfection of Hepatocyte Growth Factor (HGF) Gene in Porcine Myocardial Infarction Model
Hepatocyte Growth Factor as Cardiovascular Hormone: Role of HGF in the Pathogenesis of Cardiovascular Disease
Novel Molecular Therapeutic Approach to Cardiovascular Disease Based on Hepatocyte Growth Factor (HGF)
In vivo Gene Transfer for the Therapy of Vascular Diseases
4 Strategy of Anti-aging in Adult Common Disease : Association of Hypertension, Metabolic Syndrome and Osteoporosis(Lifestyle-related Diseases and Signalling Networks in Aging,Topic 7 (TP-7) (H),The 73rd Annual Scientific Meeting of The Japanese Circulati

もっと見る

スポンサーリンク